Table 1.
Variables | All cases | Fertility information | Oncofertility consultation | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | p | Yes | No | p | |||||||
N* | % | N* | % | N* | % | N* | % | N* | % | |||
Total number of patient | ||||||||||||
536 | 1.00 | 220 | 0.41 | 316 | 0.59 | 151 | 0.28 | 385 | 0.72 | |||
Age | ||||||||||||
19–24 years | 10 | 0.02 | 6 | 0.60 | 4 | 0.40 | < 0.001 | 5 | 0.50 | 5 | 0.50 | < 0.001 |
25–29 years | 47 | 0.09 | 36 | 0.77 | 11 | 0.23 | 34 | 0.72 | 13 | 0.28 | ||
30–34 years | 162 | 0.30 | 100 | 0.62 | 62 | 0.38 | 71 | 0.44 | 91 | 0.56 | ||
35–39 years | 239 | 0.45 | 66 | 0.28 | 173 | 0.72 | 38 | 0.16 | 201 | 0.84 | ||
40 years | 78 | 0.15 | 12 | 0.15 | 66 | 0.85 | 3 | 0.04 | 75 | 0.96 | ||
MD | 0 | |||||||||||
Hospital type | ||||||||||||
Teaching Hospital | 338 | 0.63 | 176 | 0.52 | 162 | 0.48 | < 0.001 | 118 | 0.35 | 220 | 0.65 | < 0.001 |
Private Toulouse | 124 | 0.23 | 33 | 0.27 | 91 | 0.73 | 27 | 0.22 | 97 | 0.78 | ||
Private outlying | 44 | 0.08 | 3 | 0.07 | 41 | 0.93 | 3 | 0.07 | 41 | 0.93 | ||
Public outlying | 30 | 0.06 | 8 | 0.27 | 22 | 0.73 | 3 | 0.10 | 27 | 0.90 | ||
MD | 0 | |||||||||||
Oncologist gender | ||||||||||||
Female | 306 | 0.57 | 154 | 0.50 | 152 | 0.50 | < 0.001 | 103 | 0.34 | 203 | 0.66 | 0.015 |
Male | 230 | 0.43 | 66 | 0.29 | 164 | 0.71 | 48 | 0.21 | 182 | 0.79 | ||
MD | 0 | |||||||||||
Number of children | ||||||||||||
0 | 123 | 0.23 | 89 | 0.72 | 34 | 0.28 | < 0.001 | 82 | 0.67 | 41 | 0.33 | < 0.001 |
1 | 120 | 0.22 | 58 | 0.48 | 62 | 0.52 | 49 | 0.41 | 71 | 0.59 | ||
2 | 210 | 0.39 | 59 | 0.28 | 151 | 0.72 | 16 | 0.08 | 194 | 0.92 | ||
3+ | 83 | 0.15 | 14 | 0.17 | 69 | 0.83 | 4 | 0.05 | 79 | 0.95 | ||
MD | 0 | |||||||||||
Metastatic | ||||||||||||
No | 493 | 0.92 | 213 | 0.43 | 280 | 0.57 | 0.01 | 48 | 0.13 | 336 | 0.88 | < 0.001 |
Yes | 43 | 0.08 | 7 | 0.16 | 36 | 0.84 | 2 | 0.05 | 41 | 0.95 | ||
MD | 0 | |||||||||||
EDI | ||||||||||||
Quintile 1 | 132 | 0.25 | 53 | 0.40 | 79 | 0.60 | 0.75 | 37 | 0.28 | 95 | 0.72 | 0.78 |
Quintile 2 | 119 | 0.22 | 41 | 0.34 | 78 | 0.66 | 28 | 0.24 | 91 | 0.76 | ||
Quintile 3 | 95 | 0.18 | 41 | 0.43 | 54 | 0.57 | 28 | 0.29 | 67 | 0.71 | ||
Quintile 4 | 103 | 0.19 | 48 | 0.47 | 55 | 0.53 | 28 | 0.27 | 75 | 0.73 | ||
Quintile 5 | 84 | 0.16 | 36 | 0.43 | 48 | 0.57 | 29 | 0.35 | 55 | 0.65 | ||
MD | 3 | |||||||||||
CT neoadjuvant or 1st line | ||||||||||||
No | 317 | 0.60 | 125 | 0.39 | 192 | 0.61 | 0.40 | 89 | 0.28 | 228 | 0.72 | 0.84 |
Yes | 213 | 0.40 | 95 | 0.45 | 118 | 0.55 | 62 | 0.29 | 151 | 0.71 | ||
MD | 6 | |||||||||||
Year of diagnosis | ||||||||||||
2012 | 108 | 0.20 | 27 | 0.25 | 81 | 0.75 | 0.14 | 13 | 0.12 | 95 | 0.88 | 0.04 |
2013 | 88 | 0.16 | 43 | 0.49 | 45 | 0.51 | 33 | 0.38 | 55 | 0.63 | ||
2014 | 85 | 0.16 | 39 | 0.46 | 46 | 0.54 | 24 | 0.28 | 61 | 0.72 | ||
2015 | 93 | 0.17 | 38 | 0.41 | 55 | 0.59 | 30 | 0.32 | 63 | 0.68 | ||
2016 | 105 | 0.20 | 44 | 0.42 | 61 | 0.58 | 32 | 0.30 | 73 | 0.70 | ||
2017 | 57 | 0.11 | 29 | 0.51 | 28 | 0.49 | 19 | 0.33 | 38 | 0.67 | ||
MD | 0 | |||||||||||
Triple-negative | ||||||||||||
Yes | 158 | 0.29 | 55 | 0.35 | 103 | 0.65 | 0.16 | 111 | 0.29 | 267 | 0.71 | 0.46 |
No | 378 | 0.71 | 165 | 0.44 | 213 | 0.56 | 40 | 0.25 | 118 | 0.75 | ||
MD | 0 | |||||||||||
Marital status | ||||||||||||
Married | 379 | 0.77 | 161 | 0.42 | 225 | 0.58 | 0.48 | 103 | 0.27 | 283 | 0.73 | 0.10 |
Alone | 116 | 0.23 | 55 | 0.47 | 62 | 0.53 | 44 | 0.38 | 73 | 0.62 | ||
MD | 33 | |||||||||||
Family history | ||||||||||||
Yes | 109 | 0.21 | 170 | 0.73 | 62 | 0.27 | 0.93 | 30 | 0.28 | 79 | 0.72 | 0.75 |
No | 400 | 0.79 | 47 | 0.17 | 230 | 0.83 | 118 | 0.30 | 282 | 0.71 | ||
MD | 27 |
N* weighted number of cases, P P-value, MD missing data, CT chemotherapy.